2008
DOI: 10.1016/j.cpem.2007.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Management of Beta-Adrenergic Blocker Poisoning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
6

Year Published

2010
2010
2017
2017

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 86 publications
0
3
0
6
Order By: Relevance
“…En effet, les symptômes cardiaques observés (BAV, hypotension artérielle) pouvaient être expliqués par le seul bisoprolol [15]. Le lendemain, un deuxième screening toxicologique, prévu initialement pour contrôler la décroissance du β-bloquant, a révélé des concentrations hautement toxiques de l'anticalcique, qui ont ensuite perduré pendant 6 jours.…”
Section: Discussionunclassified
See 1 more Smart Citation
“…En effet, les symptômes cardiaques observés (BAV, hypotension artérielle) pouvaient être expliqués par le seul bisoprolol [15]. Le lendemain, un deuxième screening toxicologique, prévu initialement pour contrôler la décroissance du β-bloquant, a révélé des concentrations hautement toxiques de l'anticalcique, qui ont ensuite perduré pendant 6 jours.…”
Section: Discussionunclassified
“…Devant cette probable intoxication au β-bloquant, une thérapeutique par glucagon a été initiée dans le but de diminuer rapidement les doses d'adrénaline [15]. Le glucagon activerait l'adénylcyclase myocardique, stimulant ainsi la synthèse d'AMP cyclique cardiaque [16].…”
Section: éVolutionunclassified
“…If intubation is needed, pretreatment with atropine should be considered to mitigate potential vagal-induced bradycardia (Anderson, 2007). Coreg and labetolol are known to cause significant hypotension due to their combined beta 1 blockade and vasodilating effects.…”
Section: Clinical Pearls-beta Blockermentioning
confidence: 99%
“…Glucagon's therapeutic effects may decline over time due to loss of ability to increase cAMP levels and in some situations repeated boluses may be preferred (Anderson, 2007). Large doses up to 10 g may be needed.…”
Section: Ccb Antidotes/binding Agents/treatmentmentioning
confidence: 99%
“…Beta-adrenergic antagonists competitively antagonize the effects of catecholamines at the beta-adrenergic receptor and blunt the chronotropic and inotropic response to catecholamines (Bird, 2007). Inhibition of the conducting system most commonly causes first-degree AV block, but higher levels of toxicity can promote second-and third-degree AV block ( fig.15), junctional rhythms, and intraventricular conduction delays (Anderson, 2008). Three beta-blockers are known to prolong QTc intervals: Sotalol ( fig.16), Propranolol, and Acebutolol.…”
Section: Beta-adrenergic Blockers (Bb)mentioning
confidence: 99%